MALY TIEV: Open Payments
NPI 1508147398 · BETHPAGE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$27,494 in 85 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $5,292 · 2025 $27,494
Consulting: $11,025Speaker / faculty: $7,965Travel & lodging: $4,973Food & beverage: $3,531
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 31 | $13,694 |
| Mirum Pharmaceuticals, Inc. | 20 | $7,542 |
| Gilead Sciences, Inc. | 14 | $4,297 |
| Ipsen Biopharmaceuticals, Inc | 10 | $1,540 |
| Novo Nordisk Inc | 3 | $227 |
| ORPHALAN INC | 2 | $54 |
| Intra-Sana Laboratories | 1 | $50 |
| ABBVIE INC. | 1 | $34 |
| Dexcom, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $17 |
Products named: REZDIFFRA, Livmarli, Livdelzi, IQIRVO, Wegovy, CUVRIOR, RELTONE 200 MG, MAVYRET.
Industry payments across NY — which companies pay providers there.
